Thomas Bartrum News Today

Shares of Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) gapped up prior to trading on Friday following insider buying activity. The stock had previously closed at $16.11, but opened at $17.14. Privia Health Group shares last traded at $16.70, with a volume of 204,578 shares traded. Specifically, CFO David Mountcastle sold 3,933 shares […]

Privia Health Group (NASDAQ:PRVA – Free Report) had its target price decreased by Barclays from $22.00 to $19.00 in a research report sent to investors on Monday morning, Benzinga reports. Barclays currently has an equal weight rating on the stock. PRVA has been the subject of a number of other reports. Bank of America cut […]

Privia Health Group (NASDAQ:PRVA – Free Report) had its target price trimmed by Truist Financial from $28.00 to $24.00 in a report published on Wednesday, Benzinga reports. They currently have a buy rating on the stock. A number of other research firms also recently weighed in on PRVA. TD Cowen cut their price target on […]

Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) EVP Thomas Bartrum sold 2,252 shares of the business’s stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total transaction of $41,481.84. Following the sale, the executive vice president now owns 103,862 shares in the […]

Handelsbanken Fonder AB increased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) by 41.5% during the fourth quarter, HoldingsChannel.com reports. The fund owned 15,000 shares of the company’s stock after buying an additional 4,400 shares during the quarter. Handelsbanken Fonder AB’s holdings in Privia Health Group were worth $345,000 as […]

Privia Health Group, Inc. announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective January 29, 2024. Mr. Fargis will serve as the...

ProShare Advisors LLC acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) during the second quarter, HoldingsChannel reports. The institutional investor acquired 11,247 shares of the company’s stock, valued at approximately $294,000. Other hedge funds and other institutional investors also recently added to or reduced their stakes in the […]

Senator Investment Group LP raised its stake in Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) by 3.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 775,000 shares of the company’s stock after acquiring an additional 25,000 shares during the quarter. Senator […]

Privia Health Group (NASDAQ:PRVA – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $43.00 to $38.00 in a report issued on Friday morning, Benzinga reports. They currently have an overweight rating on the stock. A number of other brokerages have also commented on PRVA. UBS Group cut their target price […]

Rhenman & Partners Asset Management AB grew its stake in Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) by 16.3% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 460,000 shares of the company’s stock after purchasing an additional 64,333 shares during […]